SCHEMBL7222809

SCHEMBL7222809

Cc1ccc(-c2ccc3c(c2)C=C(C(=O)N[C@H]2CC[C@H](CN(C)C4CCOCC4)CC2)CCO3)cc1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 18/20 0.54
CCR2 P41597 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222814 1.00 CCR5 (0.54) CCR5CCR2
SCHEMBL7218235 0.92 CCR2 (0.47) CCR5CCR2
SCHEMBL7218233 0.92 CCR2 (0.47) CCR5CCR2
Hydrochloric Acid SCHEMBL7216657 0.91 CCR5 (0.46) CCR5CCR2
Hydrochloric Acid SCHEMBL7216653 0.91 CCR5 (0.46) CCR5CCR2
SCHEMBL7221437 0.87 CCR2 (0.67) CCR5CCR2
SCHEMBL7221440 0.87 CCR2 (0.67) CCR5CCR2
SCHEMBL7215865 0.86 CCR5 (0.42) CCR5CCR2
SCHEMBL7215861 0.86 CCR5 (0.42) CCR5CCR2
SCHEMBL7216631 0.85 CCR5 (0.51) CCR5CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed